The 20 Best Malignant Mixed Mullerian Tumor Doctors Near Me in Bethesda, MD

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy. Dr. Tanner is board certified in American Board Of Obstetrics And Gynecology.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Dr. Mildred R. Chernofsky is a gynecologic oncologist at Sibley Memorial Hospital and an associate professor in obstetrics and gynecology at George Washington University School of Medicine and the Uniformed Services University of the Health Sciences (USUHS). She practices out of the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. Dr. Chernofsky is affiliated with Sibley Memorial Hospital and George Washington University Hospital. With a focus on gynecology and obstetrics, Dr. Chernofsky has an expertise in advanced laparoscopy, gestational trophoblastic disease and robotic surgery. Dr. Chernofsky earned her medical degree from Pennsylvania State University College of Medicine. She completed a general internship and a residency in obstetrics and gynecology at the National Naval Medical Center of San Diego, as well as a fellowship in gynecologic oncology at the Los Angeles County/University of Southern California Medical Center. Dr. Chernofsky was named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly in 2012 and 2014. She was also named a Top Doctor in the D.C. region by Washingtonian Magazine. Dr. Chernofsky is also a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Chernofsky has clinical interests in uterine, ovarian, cervical and vulvar cancers, as well as genital dysplasia. She has contributed to numerous clinical trials in her position as a principal investigator for Gynecologic Oncology Group (GOG), as well as various publications and presentations. Dr. Chernofsky also participates in patient educational forums both locally and those sponsored by the Foundation for Women’s Cancer. Dr. Chernofsky is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Hysterectomy. Dr. Chernofsky is board certified in American Board Of Obstetrics And Gynecology.

Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. Dr. Smith is board certified in American Board Of Internal Medicine.

Nicholas Farrell is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Farrell is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia. Dr. Farrell is board certified in American Board Of Internal Medicine.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. Staples sees patients Monday thru Friday in Building D, Level 4. Dr. Jeanine Staples is a fellowship-trained gynecologic oncologist with the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. She is trained in advanced laparoscopic and robotic surgical techniques. She has a special interest in the surgical management of gynecologic malignancies and preinvasive diseases of the vulva, vagina and cervix in addition to complex benign gynecologic diseases. She holds a masters degree in public health and her areas of research interest include screening and prevention of gynecologic malignancies as well as disparities in outcomes of women with gynecologic cancers. Dr. Staples is passionate about reducing disparities in gynecologic cancers through community engagement and education. Dr. Staples has given national presentations and lectures on these topics and is published in the field. She is also passionate about HPV vaccination and serves as a member of the Cancer Action Coalition of Virginia's HPV Taskforce Committee. Videos The Importance of Good Gynecologic Health Selected Publications Staples JN, Duska L. Cancer Screening and Prevention Highlights in Gynecologic Cancer. Obstet Gynecol Clin North Am 2019 Mar;46(1):19-36. PMID: 30683264 Staples JN, Lester J, Li A, Walsh C, Cass I, Karlan BY, Bresee C, Rimel BJ. Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients. Applied Cancer Research 2018; 38:14 Staples JN, Peres LC, Camacho TF, Alberg AJ, Bandera EV, Barnoltz-Sloan J, Bondy ML, Crote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Schildkraut JM. Cardiovascular co-morbidities and risk of ovarian carcinoma among African-American women in the African American Cancer Epidemiology Study (AACES). Gynecologic Oncology 2020 Jul; 158: 123-129. PMID: 32362566 Staples JN, Wong MS, Rimel BJ. An Educational Intervention to Improve HPV and Cervical Cancer Knowledge Among African American College Students. Gynecologic Oncology 2018; 149(1):101-105. PMID: 29605043 Patel S, Staples JN, Garcia C, Chatfield L, Ferriss JS, Duska LR. Are minority women less likely to participate in clinical trials? Gynecologic Oncology 2020 May; 157(2):323-328. PMID: 32253046 Lectures & Presentations Racial disparities in surgical outcomes of patients undergoing debulking surgery for ovarian cancer, Oral Presentation, Grand Rounds, University of Virginia Department of Obstetrics and Gynecology, Charlottesville, VA, 6/3/20. Dr. Staples is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her clinical expertise encompasses Neonatal Ovarian Cyst, Ovarian Cysts, Endometrial Cancer, Ovarian Carcinosarcoma, and Hysterectomy. Dr. Staples is board certified in American Board Of Obstetrics And Gynecology.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

James Barter is an Oncologist practicing medicine in Rockville, Maryland. Dr. Barter is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Ovarian Cysts, Neonatal Ovarian Cyst, Endometrial Cancer, Hysterectomy, and Oophorectomy.

Jeffrey Lin is a General Surgeon practicing medicine in Washington, Washington, D.c.. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Endometrial Cancer, Hernia Surgery, and Bladder Reconstruction.

Dr. Vivian M. Fraga is an obstetrician and gynecologist affiliated with Sibley Memorial Hospital, as well as an instructor at Georgetown University School of Medicine. She has a private practice in Chevy Chase, MD. Dr. Fraga earned her medical degree from Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Georgetown University Hospital. Dr. Fraga is a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Fraga has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly. Dr. Fraga is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Pelvic Inflammatory Disease, and Vulvovaginitis. Dr. Fraga is board certified in American Board Of Obstetrics And Gynecology.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia. Dr. Fishman is board certified in American Board Of Internal Medicine.

Carolyn Hendricks is a Hematologist Oncology specialist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Hendricks is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer. Dr. Hendricks is board certified in American Board Of Internal Medicine.

Dr. James Xu received a bachelor of science in chemical engineering with a minor in mathematics from Brigham Young University and his medical degree from University of Minnesota. He completed his internal medicine residency at the Yale-New Haven Hospital of Yale University in New Haven, CT, and his hematology and medical oncology fellowship at the New York-Presbyterian Hospital of Columbia University in New York City. Because of his unique background in engineering and medicine, Dr. Xu was the recipient of the American Society of Clinical Oncology-Conquer Cancer Foundation Young Investigator Award in 2011 and Merit Award in 2012. Dr. Xu is a strong advocate of precision medicine and he is the first person to have proposed and preliminarily confirmed the feasibility of using deep sequencing technology to detect genetic mutation in rare cell samples such as circulating tumor cells from cancer patients’ peripheral blood. He has published in peer-reviewed journals in lung, breast, and pancreatic cancers. Dr. Xu is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Deep Vein Thrombosis, Protein S Deficiency, and Hereditary Resistance to Anti-Vitamin K. Dr. Xu is board certified in American Board Of Internal Medicine.

"Shannon C. O'Connor, M.D., is a medical oncologist with Suburban Hospital. She practices out of Maryland Oncology Hematology. Dr. O'Connor has expertise in hematology and medical oncology with a special focus in women's health, including breast cancer and gynecologic cancers. Dr. O'Connor earned her Master's Degree in Physiology at Georgetown University, followed by her medical degree from St. George's University School of Medicine. She completed a residency at Washington Hospital Center, as well as a fellowship in hematology and oncology. Dr. O'Connor is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Montgomery County Medical Society and the American Medical Association. Selected Publications Catlett JP1, Williams SA, O'Connor SC, Krishnan J, Malkovska V. ""Primary lymphoma of bone: an institutional experience."" Leuk Lymphoma. 2008 Nov;49(11):2125-32. doi: 10.1080/10428190802404030.". Dr. O'connor is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 46 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer. Dr. O'connor is board certified in American Board Of Internal Medicine.

John O'boyle is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Silver Spring, Maryland. Dr. O'boyle is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Malignant Mixed Mullerian Tumor, Hysterectomy, and Bladder Reconstruction. Dr. O'boyle is currently accepting new patients.

Andrew Saltzman is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Silver Spring, Maryland. Dr. Saltzman is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Oophorectomy. Dr. Saltzman is currently accepting new patients.

Willard Barnes is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Barnes is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Testicular Yolk Sac Tumor, and Oophorectomy.

Louis Dainty is an Obstetrics and Gynecologist practicing medicine in Washington, Washington, D.c.. Dr. Dainty is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, Hernia Surgery, and Bladder Reconstruction.